will look to start buying in low 12s tomorrow. long term prospects are still good. caught in market/bio downturn, generic news and nothing new on the rat or europe partner. if market/bio downturn continues with no news from OMER, could see $10. that would be a GREAT long term opportunity. CEO is good, though very conservative in his guidance
If they have a good meeting with FDA on OMS 721 that news should drive the stock higher. Also need the studies restarted from the rat issue and European partner. Watching here to see if we get into 12s to add more. Think we will be back to $18-$20 by year end
I bought huge position at $5 and sold it at $25 junior and made more on that one trade than you have made in your lifetime. You don't know anything about the company, that's lose btw. I will make another killing when I rebuy under $12
platform. Also, lossing some credibility as they have been saying rat issue trials will likely be restarted soon and that was over 6 months ago.
LOl -- another great post from the small timer. Do you just it at your computer all day waiting to post bitter/angry posts? Get a life small timer
I still like it long term, just a bit frustrated with mgmt and lack of news on Europe and rat trials. Understand bios are getting killed across the board.
that's a yawner. you are not very witty on top of being an amateur investor. stick to your turd talk small timer